Insider Trading26 Jun 2026, 12:30 pm

Sanofi Consumer Healthcare India Ltd Closes Trading Window for Q2 2026 Results

AI Summary

Sanofi Consumer Healthcare India Ltd has announced the closure of its trading window to comply with its Insider Trading Code. This closure is in preparation for the declaration of the Unaudited Standalone Financial Results for the quarter and half-year ending June 30, 2026. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the results are officially announced to the stock exchanges. This measure is standard practice to prevent potential insider trading activities.

Key Highlights

Trading window closed for Q2 2026 financial results announcement.
Closure effective from July 1, 2026.
Window reopens 48 hours post-results disclosure.
Aims to prevent insider trading by designated persons.
Standard corporate governance procedure.

View BSE Filing

SANOFICONR

Pharmaceuticals

Sanofi Consumer Healthcare India Ltd

Price Impact